Exploring the future of SARS-CoV-2 treatment after the first two years of the pandemic: A comparative study of alternative therapeutics

Exploring the future of SARS-CoV-2 treatment after the first two years of the pandemic: A comparative study of alternative therapeutics

One of the most pressing challenges associated with SARS-CoV-2 treatment is the emergence of new variants that may be more transmissible, cause more severe disease, or be resistant to current treatments and vaccines. The emergence of SARS-CoV-2 has led to a global pandemic, resulting in millions of...

Full description

Bibliographic Details
Main Authors: Benjamin Ayodipupo Babalola, Oluwamayowa Samuel Akinsuyi, Elizabeth Oreoluwa Folajimi, Folakemi Olujimi, Ahmed Adebisi Otunba, Bruno Chikere, Ibitayo Ajayi Adewumagun, Tosin Emmanuel Adetobi
Format: Article
Language:English
Published: Elsevier 2023-09-01
Series:Biomedicine & Pharmacotherapy
Subjects:
SARS-CoV-2
Antiviral alternatives
Antisense oligonucleotides
Neutralizing monoclonal antibodies
CRISPR/Cas
Online Access:http://www.sciencedirect.com/science/article/pii/S0753332223008909

Internet

http://www.sciencedirect.com/science/article/pii/S0753332223008909

Similar Items